Rewalk Robotics Ltd
NASDAQ:RWLK
Intrinsic Value
ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. [ Read More ]
The intrinsic value of one RWLK stock under the Base Case scenario is 0.3332 USD. Compared to the current market price of 0.9652 USD, Rewalk Robotics Ltd is Overvalued by 65%.
Valuation Backtest
Rewalk Robotics Ltd
Run backtest to discover the historical profit from buying and selling RWLK stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Rewalk Robotics Ltd
Current Assets | 44.4m |
Cash & Short-Term Investments | 32.6m |
Receivables | 3.5m |
Other Current Assets | 8.3m |
Non-Current Assets | 24.8m |
PP&E | 3.1m |
Intangibles | 20.9m |
Other Non-Current Assets | 770k |
Current Liabilities | 12.8m |
Accounts Payable | 5.7m |
Accrued Liabilities | 3m |
Other Current Liabilities | 4.2m |
Non-Current Liabilities | 4.6m |
Other Non-Current Liabilities | 4.6m |
Earnings Waterfall
Rewalk Robotics Ltd
Revenue
|
9.2m
USD
|
Cost of Revenue
|
-6.5m
USD
|
Gross Profit
|
2.7m
USD
|
Operating Expenses
|
-25.2m
USD
|
Operating Income
|
-22.5m
USD
|
Other Expenses
|
690k
USD
|
Net Income
|
-21.8m
USD
|
Free Cash Flow Analysis
Rewalk Robotics Ltd
RWLK Profitability Score
Profitability Due Diligence
Rewalk Robotics Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
Rewalk Robotics Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
RWLK Solvency Score
Solvency Due Diligence
Rewalk Robotics Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Score
Rewalk Robotics Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RWLK Price Targets Summary
Rewalk Robotics Ltd
According to Wall Street analysts, the average 1-year price target for RWLK is 3 USD .
Ownership
RWLK Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
RWLK Price
Rewalk Robotics Ltd
Average Annual Return | -30.23% |
Standard Deviation of Annual Returns | 17.79% |
Max Drawdown | -94% |
Market Capitalization | 57.9m USD |
Shares Outstanding | 60 024 600 |
Percentage of Shares Shorted | 2.77% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The firm offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities, and is custom fitted for each user. ReWalk Rehabilitation is designed for use by paraplegia patients in the clinical rehabilitation environment, where it provides exercise and therapy.
Contact
IPO
Employees
Officers
The intrinsic value of one RWLK stock under the Base Case scenario is 0.3332 USD.
Compared to the current market price of 0.9652 USD, Rewalk Robotics Ltd is Overvalued by 65%.